0001209191-20-046372.txt : 20200812 0001209191-20-046372.hdr.sgml : 20200812 20200812163059 ACCESSION NUMBER: 0001209191-20-046372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200811 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERQUIST JOSEPH A CENTRAL INDEX KEY: 0001487224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 201095817 MAIL ADDRESS: STREET 1: QUAKER CHEMICAL CORPORATION STREET 2: ONE QUAKER PARK, 901 E. HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428-2380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-11 0 0000081362 QUAKER CHEMICAL CORP KWR 0001487224 BERQUIST JOSEPH A ONE QUAKER PARK 901 E. HECTOR STREET CONSHOHOCKEN PA 19428-2380 0 1 0 0 SVP, GL SPEC BUS & CSO Common Stock 2020-08-11 4 M 0 2188 134.60 A 14703 D Common Stock 2020-08-11 4 S 0 1988 201.97 D 12715 D Common Stock 2020-08-11 4 S 0 200 202.61 D 12515 D Common Stock 2020-08-11 4 M 0 1660 151.75 A 14175 D Common Stock 2020-08-11 4 S 0 1188 201.75 D 12987 D Common Stock 2020-08-11 4 S 0 472 202.68 D 12515 D Common Stock 1596 I By 401(k) Employee Stock Option (right to buy) 134.60 2020-08-11 4 M 0 2188 0.00 D 2024-02-27 Common Stock 2188 0 D Employee Stock Option (right to buy) 151.75 2020-08-11 4 M 0 1660 0.00 D 2025-02-26 Common Stock 1660 830 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.42 to $202.41, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.575 to $202.635, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.14 to $202.13, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.41 to $203.085, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Information based on reporting person's Plan statement as of June 30, 2020. The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020. The options for this grant vest in three annual installments: 830 shares on February 26, 2019; 830 shares on February 26, 2020; and 830 shares on February 26, 2021. Victoria K. Gehris, Attorney-in-Fact for Joseph A. Berquist 2020-08-12